Work

Preliminary results of anlotinib combined with gemcitabine and docetaxel for recurrent or metastatic primary malignant bone tumors: An open-label, single-arm, multicenter clinical trial.

Year: 2025

Type: conference-abstract

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e23507

Authors: Yiying Bian, Xianbiao Xie, Gang Huang, Junqiang Yin, Zhenchao Yuan, Changye Zou, Bing Zhang, Jingnan Shen

Institutions: Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Jiangxi University of Traditional Chinese Medicine, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410815388

Cites:

Cited by:

Related to: 10